DermTech, Inc. Common Stock

Go to DermTech, Inc. Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$20.9 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

DermTech (NASDAQ:DMTK) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 2 0 0 1M Ago 0 0 0 0 0 2M Ago 1 0 1 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $1.41, a high estimate of $2.00, and a low estimate of $0.63. A 56.62% drop is evident in the current average compared to the previous average price target of $3.25. Breaking Down Analyst Ratings: A Detailed Examination The perception of DermTech by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Thomas Flaten Lake Street Announces Hold $0.63 - Mason Carrico Stephens & Co. Maintains Equal-Weight $1.50 - Mark Massaro BTIG Lowers Buy $2.00 $4.00 Mason Carrico Stephens & Co. Lowers Equal-Weight $1.50 $2.50 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to ...Full story available on Benzinga.com

Related tickers: DMTK, DMTK.

Read Full Article

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77. Zscaler shares fell 10.1% to $217.43 on Friday. Here are some other stocks moving in today's mid-day session. Gainers BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock. The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results. Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26. Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798. Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results. MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61. Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo. NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results ...

Related tickers: ROOT, VLCN, SCLX, OPRA, SIDU, DNA, GRTS, GIA, DCFC, REAL, YMAB, DELL, SOUN, NYCB, ARVN, HLTH, VANI, DMTK, JAGX, ESTC, JAKK, LIFW, RILY, DTIL, NTAP, VYX, RGNX, RPAY, RDNT, SENS, CRDF, RMBS, EVBG, ACIC, TTEC, BIVI, MINM, COO, SG, SANA, FSR, MYO, NXU, MTZ, MTC, HUMA, PX, ADIL, XPOF, TDW, ZS, VTYX, XEL.

Read Full Article
Trending Tickers
DATS

XNAS

$1.28
0.05 (4.07%)
LASE

XNAS

$2.02
-0.17 (-7.76%)
NYCB

XNYS

$2.98
-0.09 (-2.93%)
PACW

XNAS

$0.00
(%)
MLGO

XNAS

$2.42
-0.05 (-2.02%)